S. Björkman

发表

Comparative tissue concentration profiles of fentanyl and alfentanil in humans predicted from tissue/blood partition data obtained in rats.

H Harashima, D R Stanski, D Verotta, 1990, Anesthesiology.

Determination of the steady state tissue distribution of midazolam in the rat.

S. Björkman, A. Fyge, Z. Qi, 1996, Journal of pharmaceutical sciences.

Prediction of the volume of distribution of a drug: which tissue‐plasma partition coefficients are needed?

S. Björkman, 2002, The Journal of pharmacy and pharmacology.

Cerebral pharmacodynamics of anaesthetic and subanaesthetic doses of ketamine in the normoventilated pig

I. Rosén, S. Björkman, K. Messeter, 1993, Acta anaesthesiologica Scandinavica.

In‐vitro release of bupivacaine from injectable lipid formulations investigated by a single drop technique — relation to duration of action in‐vivo

S. Björkman, L. Söderberg, H. Dyhre, 2002, The Journal of pharmacy and pharmacology.

The "inverted cup" -- a novel in vitro release technique for drugs in lipid formulations.

S. Björkman, L. Söderberg, H. Dyhre, 2006, Journal of Controlled Release.

Ultralong Peripheral Nerve Block by Lidocaine:Prilocaine 1:1 Mixture in a Lipid Depot Formulation: Comparison of In Vitro, In Vivo, and Effect Kinetics

S. Björkman, L. Söderberg, H. Dyhre, 2006, Anesthesiology.

Measurement of factor VIII pharmacokinetics in routine clinical practice

P. Collins, S. Björkman, Peter Collins, 2013, Journal of thrombosis and haemostasis : JTH.

Implications of coagulation factor VIII and IX pharmacokinetics in the prophylactic treatment of haemophilia

M. Morfini, V. Blanchette, K. Fischer, 2011, Haemophilia : the official journal of the World Federation of Hemophilia.

Limited blood sampling for pharmacokinetic dose tailoring of FVIII in the prophylactic treatment of haemophilia A

S. Björkman, 2010, Haemophilia : the official journal of the World Federation of Hemophilia.

Pharmacokinetics and dose requirements of factor VIII over the age range 3–74 years

S. Jönsson, S. Björkman, A. Folkesson, 2009, European Journal of Clinical Pharmacology.

Clinical pharmacokinetic studies on factor VIII and factor IX – experiences from the Malmö centre

S. Björkman, 2006 .

A 6‐year follow‐up of dosing, coagulation factor levels and bleedings in relation to joint status in the prophylactic treatment of haemophilia

J. Ahnström, E. Berntorp, S. Björkman, 2004, Haemophilia : the official journal of the World Federation of Hemophilia.

Prophylactic dosing of factor VIII and factor IX from a clinical pharmacokinetic perspective

S. Björkman, 2003, Haemophilia : the official journal of the World Federation of Hemophilia.

Factor VIII requirement to maintain a target plasma level in the prophylactic treatment of severe hemophilia A: influences of variance in pharmacokinetics and treatment regimens

K. Fischer, G. Spotts, V. Blanchette, 2010, Journal of thrombosis and haemostasis : JTH.

Reduction and Lumping of Physiologically Based Pharmacokinetic Models: Prediction of the Disposition of Fentanyl and Pethidine in Humans by Successively Simplified Models

S. Björkman, 2003, Journal of Pharmacokinetics and Pharmacodynamics.

Gas chromatography of cannabis constituents, including cannabinoid acids, with on-column alkylation and esterification

S. Björkman, 1982 .

Application of Pharmacokinetic Data from Healthy Volunteers for the Prediction of Plasma Concentrations of Tranexamic Acid in Surgical Patients

H. Fredin, S. Björkman, G. Benoni, 1995 .

Inclusion of lignocaine base into a polar lipid formulation –in vitro release, duration of peripheral nerve block and arterial blood concentrations in the rat

S. Björkman, S. Engström, R. Wallin, 2001, Acta anaesthesiologica Scandinavica.

Gamma camera imaging of platinum in tumours and tissues of patients after administration of 191Pt-cisplatin.

R Wallin, H. Lundqvist, S. Mattsson, 1999, Acta oncologica.

Comparative renal, hepatic, and bone marrow toxicity of Cisplatin and radioactive Cisplatin (191Pt) in Wistar rats.

S. Mattsson, K. Norrgren, L. Johansson, 2006, Cancer biotherapy & radiopharmaceuticals.

Cyclooxygenase inhibition causes marked impairment of renal function in elderly subjects treated with diuretics and ACE‐inhibitors

P. Höglund, S. Björkman, T. Juhlin, 2005, European journal of heart failure.

Acute administration of diclofenac, but possibly not long term low dose aspirin, causes detrimental renal effects in heart failure patients treated with ACE‐inhibitors

P. Höglund, S. Björkman, A. Fyge, 2004, European journal of heart failure.

Development of a Whole-Body Physiologically Based Pharmacokinetic Model for Colistin and Colistin methanesulfonate (CMS) in Rat

M. Karlsson, W. Couet, L. Friberg, 2016 .

Enantiospecific Reassessment of the Pharmacokinetics and Pharmacodynamics of Oral Eflornithine against Late-Stage Trypanosoma brucei gambiense Sleeping Sickness

M. Ashton, K. Na-Bangchang, R. Jansson-Löfmark, 2014, Antimicrobial Agents and Chemotherapy.

Pharmacokinetics of Coagulation Factors

E. Berntorp, S. Björkman, 2001, Clinical pharmacokinetics.

Pharmacokinetics and antidiuretic effect of high-dose desmopressin in patients with chronic renal failure.

S. Lethagen, G. Sterner, S. Björkman, 2003, Pharmacology & toxicology.

Tailored pharmacokinetic dosing allows self-administration and reduces the cost of IV augmentation therapy with human α1-antitrypsin

E. Berntorp, E. Piitulainen, S. Björkman, 2003, European Journal of Clinical Pharmacology.

Prediction of Cytochrome P450-Mediated Hepatic Drug Clearance in Neonates, Infants and Children

S. Björkman, 2012, Clinical pharmacokinetics.

Influence of Escherichia coli endotoxin on the pharmacokinetics and respiratory depressant effect of alfentanil in rabbits.

S. Björkman, F. Redke, 1996, Journal of pharmaceutical sciences.

Ketamine antagonises alfentanil‐induced hypoventilation in healthy male volunteers

H. Scheinin, L. Gustafsson, S. Björkman, 1999, Acta anaesthesiologica Scandinavica.

Congestive heart failure in rabbits after a single intrapleural administration of a low dose of doxorubicin or epirubicin.

S. Björkman, L. Elisson, 1988, Pharmacology & toxicology.

Consensus perspectives on prophylactic therapy for haemophilia: summary statement

J. Astermark, P. Giangrande, R. Ljung, 2003, Haemophilia : the official journal of the World Federation of Hemophilia.

A new method for enumeration of platelets.

S. Björkman, 1959 .

The pharmacokinetics of clotting factor therapy

E. Berntorp, S. Björkman, 2003, Haemophilia : the official journal of the World Federation of Hemophilia.

Chronic refractory anemia with sideroblastic bone marrow; a study of four cases.

S. Björkman, 1956 .

Clearance of Fentanyl, Alfentanil, Methohexitone, Thiopentone and Ketamine in Relation to Estimated Hepatic Blood Flow in Several Animal Species: Application to Prediction of Clearance in Man

S. Björkman, F. Redke, 2000, The Journal of pharmacy and pharmacology.

Pharmacokinetics and clinical experience of 20-h infusions of methohexitone in intensive care patients with postoperative pyrexia.

S. Björkman, B. Rosberg, F. Redke, 1991, British journal of anaesthesia.

Cerebral uptake of morphine in the pig calculated from arterio-venous plasma concentration gradients: an alternative to tissue microdialysis.

L. Gustafsson, S. Björkman, A. Fyge, 1995, Life sciences.

Long term high dose morphine, ketamine and midazolam infusion in a child with burns.

I. Choonara, A. Rane, S. Björkman, 1990, British journal of clinical pharmacology.

Effects of pentoxifylline and its metabolites on platelet aggregation in whole blood from healthy humans.

P. Höglund, M. Magnusson, E. Berntorp, 2008, European journal of pharmacology.

A placebo-controlled study of retinal blood flow changes by pentoxifylline and metabolites in humans.

P. Höglund, M. Magnusson, A. Heijl, 2006, British journal of clinical pharmacology.

Stereoselective metabolism of pentoxifylline in vitro and in vivo in humans.

M. Jönsson, P. Höglund, S. Björkman, 2002, Chirality.

Cerebral vasoconstriction by indomethacin in intracranial hypertension. An experimental investigation in pigs.

C. Nordström, I. Rosén, S. Björkman, 1995 .

Low‐dose midazolam antagonizes cerebral metabolic stimulation by ketamine in the pig

I. Rosén, S. Björkman, K. Messeter, 1993, Acta anaesthesiologica Scandinavica.

Endotoxin‐induced Fever Increases the Clearance of Methohexitone in Rabbits

S. Björkman, F. Redke, 1994, The Journal of pharmacy and pharmacology.

The effect of thiopental on cerebral blood flow, and its relation to plasma concentration, during simulated induction of anaesthesia in a porcine model

I. Rosén, S. Björkman, K. Messeter, 1994, Acta anaesthesiologica Scandinavica.

Pharmacokinetics of recombinant factor IX in relation to age of the patient: implications for dosing in prophylaxis

A. Shapiro, E. Berntorp, S. Björkman, 2001, Haemophilia : the official journal of the World Federation of Hemophilia.

Bioavailability of cyclosporine in rats after intragastric administration: a comparative study of the L2-phase and two other lipid-based vehicles.

H. Ekberg, M. Bojrup, H. Ljusberg-Wahren, 1996, Transplant immunology.

Population pharmacokinetics of recombinant factor VIII: the relationships of pharmacokinetics to age and body weight.

G. Spotts, V. Blanchette, K. Fischer, 2012, Blood.

Preoperative rectal diclofenac versus paracetamol for tonsillectomy: effects on pain and blood loss

S. Björkman, J. Åkeson, A. Schmidt, 2001, Acta anaesthesiologica Scandinavica.

Trends in bleeding patterns during prophylaxis for severe haemophilia: observations from a series of prospective clinical trials

G. Spotts, V. Blanchette, K. Fischer, 2011, Haemophilia.

Break‐through bleeding in relation to predicted factor VIII levels in patients receiving prophylactic treatment for severe hemophilia A

J. Astermark, G. Spotts, V. Blanchette, 2009, Journal of thrombosis and haemostasis : JTH.

Pharmacokinetics of plasma‐derived and recombinant factor IX – implications for prophylaxis and on‐demand therapy

S. Björkman, 2013, Haemophilia : the official journal of the World Federation of Hemophilia.

Population pharmacokinetics of plasma-derived factor IX in adult patients with haemophilia B: implications for dosing in prophylaxis

S. Björkman, Victor Åhlén, 2012, European Journal of Clinical Pharmacology.

In vivo recovery of factor VIII and factor IX: intra‐ and interindividual variance in a clinical setting

E. Berntorp, S. Björkman, A. Folkesson, 2007, Haemophilia : the official journal of the World Federation of Hemophilia.

Biochemical and In Vivo Properties of High Purity Factor IX Concentrates

S. Lethagen, E. Berntorp, I. Nilsson, 1993, Thrombosis and Haemostasis.

Population pharmacokinetics of recombinant factor IX: implications for dose tailoring

S. Björkman, 2013, Haemophilia : the official journal of the World Federation of Hemophilia.

Population pharmacokinetics of plasma-derived factor IX in adult patients with haemophilia B: implications for dosing in prophylaxis

S. Björkman, Victor Åhlén, 2012, European Journal of Clinical Pharmacology.

Comparative pharmacokinetics of plasma- and albumin-free recombinant factor VIII in children and adults: the influence of blood sampling schedule on observed age-related differences and implications for dose tailoring

G. Spotts, V. Blanchette, K. Fischer, 2010, Journal of thrombosis and haemostasis : JTH.

Methods for individualising factor VIII dosing in prophylaxis

E. Berntorp, S. Björkman, M. Ar, 2014, European journal of haematology. Supplementum.

Daily dosing prophylaxis for haemophilia: a randomized crossover pilot study evaluating feasibility and efficacy

J. Astermark, R. Ljung, E. Berntorp, 2012, Haemophilia : the official journal of the World Federation of Hemophilia.

Improved cost‐effectiveness by pharmacokinetic dosing of factor VIII in prophylactic treatment of haemophilia A

R. Ljung, S. Lethagen, E. Berntorp, 1997, Haemophilia : the official journal of the World Federation of Hemophilia.

A commentary on the differences in pharmacokinetics between recombinant and plasma‐derived factor IX and their implications for dosing

S. Björkman, 2011, Haemophilia : the official journal of the World Federation of Hemophilia.

Pharmacokinetics of factor IX in patients with haemophilia B

E. Berntorp, S. Björkman, M. Carlsson, 1994, European Journal of Clinical Pharmacology.

The pharmacokinetics of factor VIII and factor IX: methodology, pitfalls and applications

S. Björkman, M. Carlsson, 1997, Haemophilia : the official journal of the World Federation of Hemophilia.

Pharmacokinetic dosing in prophylactic treatment of hemophilia A

E. Berntorp, S. Björkman, M. Carlsson, 1993, European journal of haematology.

Pharmacokinetics of Factor VIII in Humans

E. Berntorp, S. Björkman, M. Carlsson, 1992, Clinical pharmacokinetics.

Internal and External Determinants of Bleeding Patterns on Prophylaxis for Severe Haemophilia A.

J. Astermark, G. Spotts, V. Blanchette, 2007 .

Prediction of drug disposition in infants and children by means of physiologically based pharmacokinetic (PBPK) modelling: theophylline and midazolam as model drugs.

Sven Björkman, S. Björkman, 2005, British journal of clinical pharmacology.

Epsilon-aminocaproic acid (E-ACA) as a therapeutic agent based on 5 year's clinical experience.

I. Nilsson, S. Björkman, L. Andersson, 1966, Acta medica Scandinavica. Supplementum.

Adaptation of human bladder carcinoma cell lines to serum-free growth. Evidence for autocrine growth stimulation.

S. Paulie, S. Björkman, E. Jakobson, 1994, Anticancer Research.

Comparative pharmacokinetics of factor VIII and recombinant factor IX: for which coagulation factors should half‐life change with age?

S. Björkman, 2013, Haemophilia : the official journal of the World Federation of Hemophilia.

Evaluation of the TCIWorks Bayesian computer program for estimation of individual pharmacokinetics of FVIII

S. Björkman, 2011, Haemophilia : the official journal of the World Federation of Hemophilia.

Effect of Normal Variation in Factor VIII Pharmacokinetics on Prophylactic Dosing Requirements in Severe Classical Hemophilia.

G. Spotts, V. Blanchette, K. Fischer, 2008 .

Population Pharmacokinetic Model of ADVATE in Pediatric and Adult Patients with Hemophilia A.

G. Spotts, V. Blanchette, K. Fischer, 2009 .

Compared effects of the two antiinflammatory drugs indoprofen and lonazolac on thromboxane generation and on platelet aggregation, related to plasma concentrations after single oral doses.

S. Björkman, E. Vinge, 2009, Acta pharmacologica et toxicologica.

Clinical pharmacology of thalidomide

P. Höglund, T. Eriksson, S. Björkman, 2001, European Journal of Clinical Pharmacology.

A Double-Blind Study of the Sedative Effects of the Thalidomide Enantiomers in Humans

P. Höglund, T. Eriksson, S. Björkman, 1998, Journal of Pharmacokinetics and Biopharmaceutics.

Diphenhydramine active uptake at the blood-brain barrier and its interaction with oxycodone in vitro and in vivo.

T. Terasaki, M. W. Sadiq, M. Hammarlund-Udenaes, 2011, Journal of pharmaceutical sciences.

Enhanced brain delivery of the opioid peptide DAMGO in glutathione pegylated liposomes: a microdialysis study.

A. Lindqvist, P. Gaillard, J. Rip, 2013, Molecular pharmaceutics.

Gas-liquid chromatographic determination of methohexital in plasma or whole blood with electron-capture detection of the pentafluorobenzyl derivative.

S. Björkman, J. Idvall, P. Stenberg, 1983, Journal of chromatography.

A high-performance liquid chromatographic method for methohexital and thiopental in plasma or whole blood.

S. Björkman, J. Idvall, 1984, Journal of chromatography.

Intravenous Formulations of the Enantiomers of Thalidomide: Pharmacokinetic and Initial Pharmacodynamic Characterization in Man

P. Höglund, T. Eriksson, S. Björkman, 2000, The Journal of pharmacy and pharmacology.

Determination of the enantiomers of indoprofen in blood plasma by high-performance liquid chromatography after rapid derivatization by means of ethyl chloroformate.

S. Björkman, 1985, Journal of chromatography.

Oxymorphone active uptake at the blood-brain barrier and population modeling of its pharmacokinetic-pharmacodynamic relationship.

M. W. Sadiq, M. Hammarlund-Udenaes, S. Björkman, 2013, Journal of pharmaceutical sciences.

Simultaneous determination of fentanyl and alfentanil in rat tissues by capillary column gas chromatography.

D. Stanski, S. Björkman, 1988, Journal of chromatography.

5'-O-Trityl Group Promoted Directive Effect in the Preparation of 2'-O-Methylribonucleosides.

B. Öberg, J. Chattopadhyaya, S. Björkman, 1982 .

Stereospecific determination, chiral inversion in vitro and pharmacokinetics in humans of the enantiomers of thalidomide.

P. Höglund, T. Eriksson, S. Björkman, 1995, Chirality.

Enantiomers of thalidomide: blood distribution and the influence of serum albumin on chiral inversion and hydrolysis.

P. Höglund, T. Eriksson, S. Björkman, 1998, Chirality.

Handling of blood samples for determination of thalidomide.

T. Eriksson, S. Björkman, 1997, Clinical chemistry.

Determination of thalidomide in plasma and blood by high-performance liquid chromatography: avoiding hydrolytic degradation.

T. Eriksson, H. Ekberg, S. Björkman, 1992, Journal of chromatography.

The Effect of ACTH and Cortisone on the Leukocyte Count in Four Cases of Acute Leukemia

S. Björkman, 1956 .

Phenylbutazone in the treatment of temporal arteritis.

S. Björkman, 1958 .

Drug Metabolism: Hydroxylated Metabolites of Thalidomide: Formation In‐vitro and In‐vivo in Man

P. Höglund, T. Eriksson, S. Björkman, 1998, The Journal of pharmacy and pharmacology.

Preoperative diclofenac vs. paracetamol in tonsillectomy: effects on pain and bleeding

S. Björkman, J. Åkeson, A. Schmidt, 2000 .

Pharmacokinetics of midazolam given as an intranasal spray to adult surgical patients.

S. Björkman, J. Idvall, G. Rigemar, 1997, British journal of anaesthesia.

Pharmacokinetics of i.v. and rectal methohexitone in children.

J. Gabrielsson, S. Björkman, M. Corbey, 1987, British journal of anaesthesia.

Rectal induction of anaesthesia in children with methohexitone. Patient acceptability and clinical pharmacokinetics.

S. Björkman, M. Corbey, H. Quaynor, 1986, British journal of anaesthesia.

Local Anesthetics in Lipid-Depot Formulations—Neurotoxicity in Relation to Duration of Effect in a Rat Model

C. Carlsson, S. Björkman, L. Söderberg, 2006, Regional Anesthesia & Pain Medicine.

Some Attempts at Determining the Volume and Function of Each Lung Separately. (Bronchospirometry)1

S. Björkman, H. C. Jacobæus, P. Frenokner, 2009 .

RECTAL INDUCTION OF ANAESTHESIA IN CHILDREN WITH METHOHEXITONE Patient Acceptability and Clinical Pahrmacokinetics

S. Björkman, M. Corbey, H. Quaynor, 1985 .

Method for determining absolute reticulocyte count.

S. Björkman, 1958 .

Ketamine and midazolam decrease cerebral blood flow and consequently their own rate of transport to the brain: An application of mass balance pharmacokinetics with a changing regional blood flow

S. Björkman, K. Messeter, J. Åkeson, 1992, Journal of Pharmacokinetics and Biopharmaceutics.

A Whole‐Body Physiologically Based Pharmacokinetic Model for Colistin and Colistin Methanesulfonate in Rat

M. Karlsson, W. Couet, L. Friberg, 2018, Basic & clinical pharmacology & toxicology.

Comparative physiological pharmacokinetics of fentanyl and alfentanil in rats and humans based on parametric single-tissue models

Sven Björkman, Donald R. Stanski, D. Russell Wada, 1994, Journal of Pharmacokinetics and Biopharmaceutics.

Determination of the enantiomers of ketoprofen in blood plasma by ion-pair extraction and high-performance liquid chromatography of leucinamide derivatives.

S. Björkman, 1987, Journal of chromatography.

Phosphatase studies on a case of prostatic carcinoma with metastases.

S. Björkman, 2009 .

On the optimal dosage of Pro-Leu-Gly-NH2 (MIF) in neuropharmacological tests and clinical use

S. Björkman, H. Sievertsson, 1977, Naunyn-Schmiedeberg's Archives of Pharmacology.

Prediction of the disposition of midazolam in surgical patients by a physiologically based pharmacokinetic model.

G Benoni, D. R. Wada, D R Wada, 2001, Journal of pharmaceutical sciences.

THE PRODUCTION OF A PERSISTENT ALTERATION IN INFLUENZA VIRUS BY LANTHANUM OR ULTRAVIOLET IRRADIATION

F. Horsfall, S. Björkman, 1948, The Journal of experimental medicine.

Effects of dihydroergotamine and sumatriptan on isolated human cerebral and peripheral arteries and veins

C. Nordström, L. Edvinsson, T. Nilsson, 1997, Acta anaesthesiologica Scandinavica.

Determination of (R)- and (S)-propranolol in plasma by high-performance liquid chromatography using N-benzoxycarbonylglycyl-L-proline as chiral selector in the mobile phase.

C. Pettersson, S. Björkman, A. Karlsson, 1989, Journal of chromatography.

Drug exposure and flow cytometry analyses in a thalidomide treatment schedule that prolongs rat cardiac graft survival.

K. Riesbeck, T. Eriksson, H. Ekberg, 1992, Transplantation Proceedings.

Pharmacokinetics of Quinacrine after Intrapleural Instillation in Rabbits and Man

J. Gabrielsson, S. Björkman, L. Elisson, 1989, The Journal of pharmacy and pharmacology.

Determination of quinacrine (mepacrine) in plasma by high-performance liquid chromatography with fluorimetric detection.

S. Björkman, L. Elisson, 1987, Journal of chromatography.

Multidose pharmacokinetics of factor IX: implications for dosing in prophylaxis

E. Berntorp, S. Björkman, Carlsson, 1998, Haemophilia : the official journal of the World Federation of Hemophilia.

Thermic and tremorogenic effects of thyroliberin (TRH) in reserpine‐treated mice—the non‐involvement of GABA‐ergic mechanisms

T. Lewander, L. Koskinen, S. Björkman, 1981, The Journal of pharmacy and pharmacology.

A Comment on the Application of Drug Tissue-Plasma Partition Coefficients Kp in Eliminating Organs to Calculation of Volume of Distribution at Steady State

S. Björkman, 2005, Journal of Pharmacokinetics and Pharmacodynamics.

Tissue distribution of fentanyl and alfentanil in the rat cannot be described by a blood flow limited model

S. Harapat, W. Ebling, D. Stanski, 1993, Journal of Pharmacokinetics and Biopharmaceutics.

Break‐through bleeding in relation to predicted factor VIII levels in patients receiving prophylactic treatment for severe hemophilia A

J. Astermark, G. Spotts, V. Blanchette, 2009, Journal of thrombosis and haemostasis : JTH.